Health Care Archives - Page 473 of 478

1 minute read

Rhythm Shares Climb Following Positive Interim Results From Mid-Stage Obesity Study

July 12, 9:42 AM

Rhythm Pharmaceuticals (NASDAQ: RYTM) announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyperphagia in people living with hypothalamic obesity.

RYTM

2 minute read

ZimVie Announces Anthem Blue Cross Blue Shield Issued Positive Policy Decision Applicable To Anterior Vertebral Body Tethering

By Bill Haddad

July 12, 8:06 AM

ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that Anthem Blue Cross Blue Shield (BCBS), a subsidiary/operating company of Elevance Health, has issued a

ZIMV

1 minute read

Novo Integrated Shares Jump On Upbeat Q3 Interim Sales

By Vandana Singh

July 12, 5:53 AM

Novo Integrated Sciences Inc (NASDAQ:NVOS) sees Q3 FY22 sales of $13.4 million – $13.9 million, an increase of approximately 367%…

NVOS

1 minute read

Iterum Therapeutics Shares Are Surging – Read Why

By Vandana Singh

July 11, 2:31 PM

Iterum Therapeutics plc (NASDAQ:ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and…

ITRM

1 minute read

Needham Previews Neurocrine’s Upcoming Mid-Stage Data from Essential Tremor Study

By Vandana Singh

July 11, 2:20 PM

Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022.

JAZZ

1 minute read

Why NuCana Shares Are Rising Today?

By Vandana Singh

July 11, 1:36 PM

Regional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ:NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH…

GILD

1 minute read

With New Phase 3 Data From Its Hemophilia Study, Novo Nordisk Plots Route To FDA

By Vandana Singh

July 11, 1:24 PM

Novo Nordisk A/S (NYSE:NVO) announced the phase 3 results of the explorer7 study, assessing the efficacy and safety of prophylactic treatment…

NVO

1 minute read

Novo Nordisk’s Mim8 Shows Potential As Once Monthly Treatment For Hemophilia A

By Vandana Singh

July 11, 12:52 PM

Novo Nordisk A/S (NYSE:NVO) announced that the phase 1 & 2 FRONTIER1 dose-escalation study in treating people with hemophilia…

NVO

2 minute read

Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In

By Dylan Wechsler

July 11, 12:00 PM

On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC).

AAPL

1 minute read

Aethlon Medical Secures FDA Clearance For Amendment In Initial-Stage COVID-19 Study

By Ragothaman Srinivasan

July 11, 11:41 AM

The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating Aethlon Medical’s (NASDAQ: AEMD) lead therapy Aethlon Hemopurifier for patients with severe COVID-19.

AEMD